Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
29
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| McAvoy David R. | General Counsel | 3 | $0 | $0 | 2018-12-21 |
| Chelius Erik C. | Vice President CMC | 15 | $0 | $70.2K | 2018-12-21 |
| Andriole Michael T. | Chief Financial Officer | 16 | $0 | $278.8K | 2018-12-21 |
| Armour Alison A. | Chief Medical Officer | 31 | $0 | $164.4K | 2018-12-21 |
| Parker Katherine | VP of Human Resources | 21 | $0 | $210.6K | 2018-12-21 |
| Svoronos Dawn | Director | 6 | $0 | $0 | 2018-12-21 |
| Taylor Beth | VP Finance & Chief Acctg Offcr | 53 | $0 | $272.3K | 2018-12-21 |
| Low Philip S | Chief Science Officer | 93 | $67.1K | $836.9K | 2018-12-21 |
| Sherman Michael A. | President, CEO and CFO | 67 | $0 | $437.7K | 2018-12-21 |
| Leamon Christopher P | Vice President of Research | 71 | $0 | $1.22M | 2018-12-21 |
| Russell Lesley | Director | 21 | $0 | $0 | 2018-12-21 |
| Machado Patrick | Director | 9 | $0 | $0 | 2018-12-21 |
| MIDDLETON FRED A | Director | 37 | $83.9K | $0 | 2018-12-21 |
| KOZIN MARC D | Director | 20 | $0 | $0 | 2018-12-21 |
| GODDARD COLIN | Director | 18 | $0 | $0 | 2018-12-21 |
| APLIN JOHN C | Director | 22 | $0 | $0 | 2018-12-21 |
| HANHAM ANN | Director | 39 | $0 | $5.37M | 2017-05-04 |
| BRAUER KEITH E | Director | 11 | $0 | $0 | 2017-05-04 |
| MELDRUM PETER D | Director | 10 | $0 | $0 | 2017-05-04 |
| Brinkley Michael A. | Vice President of Quality | 14 | $0 | $0 | 2017-02-06 |
| Ellis P Ron | President and CEO | 44 | $0 | $397.1K | 2016-06-24 |
| Harper Scot | VP of CLINICAL OPERATIONS | 9 | $0 | $0 | 2016-02-06 |
| Nguyen Binh | VP of Medical Affairs | 15 | $0 | $422.5K | 2015-03-03 |
| Lovejoy Chandra D | VP of Regulatory Affairs | 49 | $0 | $396.3K | 2014-08-11 |
| Ritter Allen R | VP of Manufacturing/CMC | 29 | $0 | $548.1K | 2014-04-10 |
| Meek David D. | Chief Commercial Officer | 7 | $0 | $155.0K | 2014-02-06 |
| SANDERLING VENTURES MANAGEMENT V | 10% Owner | 6 | $151.3K | $0 | 2012-12-11 |
| BAILEY DOUGLAS G | Director | 1 | $0 | $0 | 2012-05-31 |
| SANDERLING V LTD PARTNERSHIP | 10% Owner | 2 | $1.26M | $0 | 2011-12-21 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Andriole Michael T. | Chief Financial Officer | D To issuer deriv | 2018-12-21 | 2018-12-21 | 50,000 | $20.99 | $1.05M | 0 | SEC↗ |
| Andriole Michael T. | Chief Financial Officer | D To issuer deriv | 2018-12-21 | 2018-12-21 | 75,000 | $21.78 | $1.63M | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | D To issuer deriv | 2018-12-21 | 2018-12-21 | 56,918 | $14.14 | $804.8K | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | D To issuer deriv | 2018-12-21 | 2018-12-21 | 36,000 | $12.89 | $464.0K | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | D To issuer deriv | 2018-12-21 | 2018-12-21 | 59,996 | $20.45 | $1.23M | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | D To issuer deriv | 2018-12-21 | 2018-12-21 | 17,950 | $12.20 | $219.0K | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | D To issuer deriv | 2018-12-21 | 2018-12-21 | 8,560 | $14.95 | $128.0K | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | D To issuer deriv | 2018-12-21 | 2018-12-21 | 13,570 | $20.18 | $273.8K | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | D To issuer deriv | 2018-12-21 | 2018-12-21 | 52,498 | $18.90 | $992.2K | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | D To issuer deriv | 2018-12-21 | 2018-12-21 | 52,498 | $20.82 | $1.09M | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | D To issuer deriv | 2018-12-21 | 2018-12-21 | 35,000 | $21.84 | $764.4K | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | D To issuer deriv | 2018-12-21 | 2018-12-21 | 45,000 | $20.99 | $944.5K | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | D To issuer deriv | 2018-12-21 | 2018-12-21 | 74,998 | $20.45 | $1.53M | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | D To issuer deriv | 2018-12-21 | 2018-12-21 | 187,500 | $21.84 | $4.09M | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | D To issuer deriv | 2018-12-21 | 2018-12-21 | 60,000 | $20.32 | $1.22M | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | D To issuer deriv | 2018-12-21 | 2018-12-21 | 20,800 | $14.95 | $311.0K | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | D To issuer deriv | 2018-12-21 | 2018-12-21 | 225,000 | $20.99 | $4.72M | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | D To issuer deriv | 2018-12-21 | 2018-12-21 | 58,719 | $14.14 | $830.3K | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | D To issuer deriv | 2018-12-21 | 2018-12-21 | 36,000 | $12.89 | $464.0K | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | D To issuer deriv | 2018-12-21 | 2018-12-21 | 86,247 | $18.90 | $1.63M | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | D To issuer deriv | 2018-12-21 | 2018-12-21 | 86,248 | $20.82 | $1.80M | 0 | SEC↗ |
| KOZIN MARC D | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 13,500 | $20.65 | $278.8K | 0 | SEC↗ |
| KOZIN MARC D | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 13,500 | $17.98 | $242.7K | 0 | SEC↗ |
| KOZIN MARC D | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 14,000 | $17.31 | $242.3K | 0 | SEC↗ |
| KOZIN MARC D | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 14,000 | $11.06 | $154.8K | 0 | SEC↗ |
| KOZIN MARC D | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 20,000 | $16.29 | $325.8K | 0 | SEC↗ |
| KOZIN MARC D | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,500 | $13.19 | $257.2K | 0 | SEC↗ |
| KOZIN MARC D | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,500 | $21.73 | $423.7K | 0 | SEC↗ |
| Svoronos Dawn | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,500 | $13.19 | $257.2K | 0 | SEC↗ |
| Svoronos Dawn | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 22,500 | $13.19 | $296.8K | 0 | SEC↗ |
| GODDARD COLIN | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,500 | $21.73 | $423.7K | 0 | SEC↗ |
| GODDARD COLIN | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,500 | $13.19 | $257.2K | 0 | SEC↗ |
| GODDARD COLIN | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 13,500 | $20.65 | $278.8K | 0 | SEC↗ |
| GODDARD COLIN | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 13,500 | $17.98 | $242.7K | 0 | SEC↗ |
| GODDARD COLIN | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 14,000 | $17.31 | $242.3K | 0 | SEC↗ |
| GODDARD COLIN | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 28,000 | $13.63 | $381.6K | 0 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | D To issuer deriv | 2018-12-21 | 2018-12-21 | 3,750 | $20.82 | $78.1K | 0 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | D To issuer deriv | 2018-12-21 | 2018-12-21 | 15,000 | $21.84 | $327.6K | 0 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | D To issuer deriv | 2018-12-21 | 2018-12-21 | 12,969 | $20.79 | $269.6K | 0 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | D To issuer deriv | 2018-12-21 | 2018-12-21 | 25,000 | $20.99 | $524.8K | 0 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | D To issuer deriv | 2018-12-21 | 2018-12-21 | 10,850 | $12.89 | $139.9K | 0 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | D To issuer deriv | 2018-12-21 | 2018-12-21 | 9,132 | $14.14 | $129.1K | 0 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | D To issuer deriv | 2018-12-21 | 2018-12-21 | 23,560 | $16.59 | $390.9K | 0 | SEC↗ |
| APLIN JOHN C | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 14,000 | $17.31 | $242.3K | 0 | SEC↗ |
| APLIN JOHN C | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,500 | $21.73 | $423.7K | 0 | SEC↗ |
| APLIN JOHN C | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 13,500 | $20.65 | $278.8K | 0 | SEC↗ |
| APLIN JOHN C | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 13,500 | $17.98 | $242.7K | 0 | SEC↗ |
| APLIN JOHN C | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,500 | $13.19 | $257.2K | 0 | SEC↗ |
| APLIN JOHN C | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 14,000 | $11.06 | $154.8K | 0 | SEC↗ |
| APLIN JOHN C | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 10,000 | $17.57 | $175.7K | 0 | SEC↗ |
| APLIN JOHN C | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 10,000 | $12.20 | $122.0K | 0 | SEC↗ |
| APLIN JOHN C | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 15,706 | $18.00 | $282.7K | 0 | SEC↗ |
| Chelius Erik C. | Vice President CMC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 11,568 | $18.90 | $218.6K | 0 | SEC↗ |
| Chelius Erik C. | Vice President CMC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 11,413 | $21.84 | $249.3K | 0 | SEC↗ |
| Chelius Erik C. | Vice President CMC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 14,062 | $20.82 | $292.8K | 0 | SEC↗ |
| Chelius Erik C. | Vice President CMC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 47,500 | $20.99 | $997.0K | 0 | SEC↗ |
| Chelius Erik C. | Vice President CMC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 10,850 | $12.89 | $139.9K | 0 | SEC↗ |
| Chelius Erik C. | Vice President CMC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 15,500 | $14.14 | $219.2K | 0 | SEC↗ |
| Chelius Erik C. | Vice President CMC | D To issuer deriv | 2018-12-21 | 2018-12-21 | 14,000 | $20.36 | $285.0K | 0 | SEC↗ |
| Russell Lesley | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,500 | $13.19 | $257.2K | 0 | SEC↗ |
| Russell Lesley | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 28,000 | $14.37 | $402.4K | 0 | SEC↗ |
| Russell Lesley | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 14,000 | $11.06 | $154.8K | 0 | SEC↗ |
| Russell Lesley | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 14,000 | $17.31 | $242.3K | 0 | SEC↗ |
| Russell Lesley | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 13,500 | $17.98 | $242.7K | 0 | SEC↗ |
| Russell Lesley | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 13,500 | $20.65 | $278.8K | 0 | SEC↗ |
| Russell Lesley | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,500 | $21.73 | $423.7K | 0 | SEC↗ |
| Parker Katherine | VP of Human Resources | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,000 | $12.53 | $238.1K | 0 | SEC↗ |
| Parker Katherine | VP of Human Resources | D To issuer deriv | 2018-12-21 | 2018-12-21 | 60,000 | $18.90 | $1.13M | 0 | SEC↗ |
| Parker Katherine | VP of Human Resources | D To issuer deriv | 2018-12-21 | 2018-12-21 | 37,500 | $20.82 | $780.8K | 0 | SEC↗ |
| Parker Katherine | VP of Human Resources | D To issuer deriv | 2018-12-21 | 2018-12-21 | 25,000 | $21.84 | $546.0K | 0 | SEC↗ |
| Parker Katherine | VP of Human Resources | D To issuer deriv | 2018-12-21 | 2018-12-21 | 25,000 | $20.99 | $524.8K | 0 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | D To issuer deriv | 2018-12-21 | 2018-12-21 | 25,000 | $18.84 | $471.0K | 0 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | D To issuer deriv | 2018-12-21 | 2018-12-21 | 45,000 | $20.99 | $944.5K | 0 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | D To issuer deriv | 2018-12-21 | 2018-12-21 | 39,999 | $21.84 | $873.6K | 0 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | D To issuer deriv | 2018-12-21 | 2018-12-21 | 45,788 | $20.82 | $953.3K | 0 | SEC↗ |
| Leamon Christopher P | Vice President of Research | D To issuer deriv | 2018-12-21 | 2018-12-21 | 35,000 | $21.84 | $764.4K | 0 | SEC↗ |
| Leamon Christopher P | Vice President of Research | D To issuer deriv | 2018-12-21 | 2018-12-21 | 27,500 | $14.95 | $411.1K | 0 | SEC↗ |
| Leamon Christopher P | Vice President of Research | D To issuer deriv | 2018-12-21 | 2018-12-21 | 45,000 | $20.99 | $944.5K | 0 | SEC↗ |
| Leamon Christopher P | Vice President of Research | D To issuer deriv | 2018-12-21 | 2018-12-21 | 52,498 | $20.82 | $1.09M | 0 | SEC↗ |
| Leamon Christopher P | Vice President of Research | D To issuer deriv | 2018-12-21 | 2018-12-21 | 52,498 | $18.90 | $992.2K | 0 | SEC↗ |
| Leamon Christopher P | Vice President of Research | D To issuer deriv | 2018-12-21 | 2018-12-21 | 45,000 | $12.89 | $580.0K | 0 | SEC↗ |
| Leamon Christopher P | Vice President of Research | D To issuer deriv | 2018-12-21 | 2018-12-21 | 70,000 | $14.14 | $989.8K | 0 | SEC↗ |
| Leamon Christopher P | Vice President of Research | D To issuer deriv | 2018-12-21 | 2018-12-21 | 59,996 | $20.45 | $1.23M | 0 | SEC↗ |
| McAvoy David R. | General Counsel | D To issuer deriv | 2018-12-21 | 2018-12-21 | 37,500 | $21.04 | $789.0K | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 22,500 | $19.80 | $445.5K | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,500 | $13.19 | $257.2K | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,500 | $21.73 | $423.7K | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 13,500 | $17.98 | $242.7K | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 13,500 | $20.65 | $278.8K | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 19,500 | $13.19 | $257.2K | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 14,000 | $17.31 | $242.3K | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 14,000 | $11.06 | $154.8K | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 10,000 | $17.57 | $175.7K | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 10,000 | $12.20 | $122.0K | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer deriv | 2018-12-21 | 2018-12-21 | 15,706 | $18.00 | $282.7K | 0 | SEC↗ |
| Andriole Michael T. | Chief Financial Officer | D To issuer | 2018-12-21 | 2018-12-21 | 52,582 | $24.00 | $1.26M | 0 | SEC↗ |
| Andriole Michael T. | Chief Financial Officer | D To issuer | 2018-12-21 | 2018-12-21 | 25,000 | $24.00 | $600.0K | 0 | SEC↗ |
| Andriole Michael T. | Chief Financial Officer | D To issuer | 2018-12-21 | 2018-12-21 | 37,500 | $24.00 | $900.0K | 0 | SEC↗ |
| Andriole Michael T. | Chief Financial Officer | D To issuer | 2018-12-21 | 2018-12-21 | 37,500 | $24.00 | $900.0K | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | D To issuer | 2018-12-21 | 2018-12-21 | 349,944 | $24.00 | $8.40M | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | D To issuer | 2018-12-21 | 2018-12-21 | 132,473 | $24.00 | $3.18M | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | D To issuer | 2018-12-21 | 2018-12-21 | 4,375 | $24.00 | $105.0K | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | D To issuer | 2018-12-21 | 2018-12-21 | 13,125 | $24.00 | $315.0K | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | D To issuer | 2018-12-21 | 2018-12-21 | 20,000 | $24.00 | $480.0K | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | D To issuer | 2018-12-21 | 2018-12-21 | 22,500 | $24.00 | $540.0K | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | D To issuer | 2018-12-21 | 2018-12-21 | 7,188 | $24.00 | $172.5K | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | D To issuer | 2018-12-21 | 2018-12-21 | 23,438 | $24.00 | $562.5K | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | D To issuer | 2018-12-21 | 2018-12-21 | 62,500 | $24.00 | $1.50M | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | D To issuer | 2018-12-21 | 2018-12-21 | 37,500 | $24.00 | $900.0K | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | D To issuer | 2018-12-21 | 2018-12-21 | 243,739 | $24.00 | $5.85M | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | D To issuer | 2018-12-21 | 2018-12-21 | 19,919 | $24.00 | $478.1K | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | D To issuer | 2018-12-21 | 2018-12-21 | 5,000 | $24.00 | $120.0K | 0 | SEC↗ |
| KOZIN MARC D | Director | D To issuer | 2018-12-21 | 2018-12-21 | 3,300 | $24.00 | $79.2K | 0 | SEC↗ |
| KOZIN MARC D | Director | D To issuer | 2018-12-21 | 2018-12-21 | 7,800 | $24.00 | $187.2K | 0 | SEC↗ |
| Svoronos Dawn | Director | D To issuer | 2018-12-21 | 2018-12-21 | 3,750 | $24.00 | $90.0K | 0 | SEC↗ |
| Svoronos Dawn | Director | D To issuer | 2018-12-21 | 2018-12-21 | 3,300 | $24.00 | $79.2K | 0 | SEC↗ |
| GODDARD COLIN | Director | D To issuer | 2018-12-21 | 2018-12-21 | 7,800 | $24.00 | $187.2K | 0 | SEC↗ |
| GODDARD COLIN | Director | D To issuer | 2018-12-21 | 2018-12-21 | 3,300 | $24.00 | $79.2K | 0 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | D To issuer | 2018-12-21 | 2018-12-21 | 12,500 | $24.00 | $300.0K | 0 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | D To issuer | 2018-12-21 | 2018-12-21 | 15,000 | $24.00 | $360.0K | 0 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | D To issuer | 2018-12-21 | 2018-12-21 | 7,500 | $24.00 | $180.0K | 0 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | D To issuer | 2018-12-21 | 2018-12-21 | 1,875 | $24.00 | $45.0K | 0 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | D To issuer | 2018-12-21 | 2018-12-21 | 1,875 | $24.00 | $45.0K | 0 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | D To issuer | 2018-12-21 | 2018-12-21 | 1,250 | $24.00 | $30.0K | 0 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | D To issuer | 2018-12-21 | 2018-12-21 | 59,509 | $24.00 | $1.43M | 0 | SEC↗ |
| APLIN JOHN C | Director | D To issuer | 2018-12-21 | 2018-12-21 | 3,300 | $24.00 | $79.2K | 0 | SEC↗ |
| APLIN JOHN C | Director | D To issuer | 2018-12-21 | 2018-12-21 | 28,863 | $24.00 | $692.7K | 0 | SEC↗ |
| Chelius Erik C. | Vice President CMC | D To issuer | 2018-12-21 | 2018-12-21 | 3,516 | $24.00 | $84.4K | 0 | SEC↗ |
| Chelius Erik C. | Vice President CMC | D To issuer | 2018-12-21 | 2018-12-21 | 16,250 | $24.00 | $390.0K | 0 | SEC↗ |
| Chelius Erik C. | Vice President CMC | D To issuer | 2018-12-21 | 2018-12-21 | 4,281 | $24.00 | $102.7K | 0 | SEC↗ |
| Chelius Erik C. | Vice President CMC | D To issuer | 2018-12-21 | 2018-12-21 | 10,000 | $24.00 | $240.0K | 0 | SEC↗ |
| Chelius Erik C. | Vice President CMC | D To issuer | 2018-12-21 | 2018-12-21 | 15,848 | $24.00 | $380.4K | 0 | SEC↗ |
| Russell Lesley | Director | D To issuer | 2018-12-21 | 2018-12-21 | 7,800 | $24.00 | $187.2K | 0 | SEC↗ |
| Russell Lesley | Director | D To issuer | 2018-12-21 | 2018-12-21 | 3,300 | $24.00 | $79.2K | 0 | SEC↗ |
| Parker Katherine | VP of Human Resources | D To issuer | 2018-12-21 | 2018-12-21 | 12,500 | $24.00 | $300.0K | 0 | SEC↗ |
| Parker Katherine | VP of Human Resources | D To issuer | 2018-12-21 | 2018-12-21 | 1,200 | $24.00 | $28.8K | 0 | SEC↗ |
| Parker Katherine | VP of Human Resources | D To issuer | 2018-12-21 | 2018-12-21 | 15,000 | $24.00 | $360.0K | 0 | SEC↗ |
| Parker Katherine | VP of Human Resources | D To issuer | 2018-12-21 | 2018-12-21 | 9,375 | $24.00 | $225.0K | 0 | SEC↗ |
| Parker Katherine | VP of Human Resources | D To issuer | 2018-12-21 | 2018-12-21 | 3,125 | $24.00 | $75.0K | 0 | SEC↗ |
| Parker Katherine | VP of Human Resources | D To issuer | 2018-12-21 | 2018-12-21 | 22,797 | $24.00 | $547.1K | 0 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | D To issuer | 2018-12-21 | 2018-12-21 | 22,500 | $24.00 | $540.0K | 0 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | D To issuer | 2018-12-21 | 2018-12-21 | 15,000 | $24.00 | $360.0K | 0 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | D To issuer | 2018-12-21 | 2018-12-21 | 20,000 | $24.00 | $480.0K | 0 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | D To issuer | 2018-12-21 | 2018-12-21 | 72,253 | $24.00 | $1.73M | 0 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | D To issuer | 2018-12-21 | 2018-12-21 | 10,500 | $24.00 | $252.0K | 0 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | D To issuer | 2018-12-21 | 2018-12-21 | 5,000 | $24.00 | $120.0K | 0 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | D To issuer | 2018-12-21 | 2018-12-21 | 5,000 | $24.00 | $120.0K | 0 | SEC↗ |
| Leamon Christopher P | Vice President of Research | D To issuer | 2018-12-21 | 2018-12-21 | 164,256 | $24.00 | $3.94M | 0 | SEC↗ |
| Leamon Christopher P | Vice President of Research | D To issuer | 2018-12-21 | 2018-12-21 | 4,375 | $24.00 | $105.0K | 0 | SEC↗ |
| Leamon Christopher P | Vice President of Research | D To issuer | 2018-12-21 | 2018-12-21 | 13,125 | $24.00 | $315.0K | 0 | SEC↗ |
| Leamon Christopher P | Vice President of Research | D To issuer | 2018-12-21 | 2018-12-21 | 20,000 | $24.00 | $480.0K | 0 | SEC↗ |
| Leamon Christopher P | Vice President of Research | D To issuer | 2018-12-21 | 2018-12-21 | 22,500 | $24.00 | $540.0K | 0 | SEC↗ |
| McAvoy David R. | General Counsel | D To issuer | 2018-12-21 | 2018-12-21 | 2,119 | $24.00 | $50.9K | 0 | SEC↗ |
| McAvoy David R. | General Counsel | D To issuer | 2018-12-21 | 2018-12-21 | 23,750 | $24.00 | $570.0K | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer | 2018-12-21 | 2018-12-21 | 1,250 | $24.00 | $30.0K | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer | 2018-12-21 | 2018-12-21 | 2,500 | $24.00 | $60.0K | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer | 2018-12-21 | 2018-12-21 | 3,300 | $24.00 | $79.2K | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer | 2018-12-21 | 2018-12-21 | 3,300 | $24.00 | $79.2K | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer | 2018-12-21 | 2018-12-21 | 110,189 | $24.00 | $2.64M | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer | 2018-12-21 | 2018-12-21 | 100,828 | $24.00 | $2.42M | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer | 2018-12-21 | 2018-12-21 | 113,315 | $24.00 | $2.72M | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer | 2018-12-21 | 2018-12-21 | 904,465 | $24.00 | $21.71M | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer | 2018-12-21 | 2018-12-21 | 1,017,304 | $24.00 | $24.42M | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer | 2018-12-21 | 2018-12-21 | 1,212,413 | $24.00 | $29.10M | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer | 2018-12-21 | 2018-12-21 | 267,491 | $24.00 | $6.42M | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer | 2018-12-21 | 2018-12-21 | 249,148 | $24.00 | $5.98M | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer | 2018-12-21 | 2018-12-21 | 162,170 | $24.00 | $3.89M | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer | 2018-12-21 | 2018-12-21 | 8,434 | $24.00 | $202.4K | 0 | SEC↗ |
| MIDDLETON FRED A | Director | D To issuer | 2018-12-21 | 2018-12-21 | 10,049 | $24.00 | $241.2K | 0 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | G Gift | 2018-12-20 | 2018-12-21 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | G Gift | 2018-12-20 | 2018-12-21 | 10,500 | — | $0 | 139,753 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | G Gift | 2018-12-19 | 2018-12-19 | 3,186 | — | $0 | 98,259 | SEC↗ |
| Parker Katherine | VP of Human Resources | G Gift | 2018-12-18 | 2018-12-21 | 8,229 | — | $0 | 62,797 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise deriv | 2018-12-17 | 2018-12-19 | 13,082 | — | $0 | 56,918 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise deriv | 2018-12-17 | 2018-12-19 | 20,004 | — | $0 | 59,996 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise deriv | 2018-12-17 | 2018-12-19 | 2,050 | — | $0 | 17,950 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise deriv | 2018-12-17 | 2018-12-19 | 21,440 | — | $0 | 8,560 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise deriv | 2018-12-17 | 2018-12-19 | 2 | — | $0 | 52,498 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise deriv | 2018-12-17 | 2018-12-19 | 22,759 | — | $0 | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise deriv | 2018-12-17 | 2018-12-19 | 2 | — | $0 | 52,498 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise deriv | 2018-12-17 | 2018-12-19 | 9,000 | — | $0 | 36,000 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise deriv | 2018-12-17 | 2018-12-19 | 51,875 | — | $0 | 13,570 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise deriv | 2018-12-17 | 2018-12-19 | 5,330 | — | $0 | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise deriv | 2018-12-17 | 2018-12-19 | 10,035 | — | $0 | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise deriv | 2018-12-17 | 2018-12-19 | 15,706 | — | $0 | 0 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise deriv | 2018-12-17 | 2018-12-19 | 39,200 | — | $0 | 20,800 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise deriv | 2018-12-17 | 2018-12-19 | 2 | — | $0 | 86,248 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise deriv | 2018-12-17 | 2018-12-19 | 3 | — | $0 | 86,247 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise deriv | 2018-12-17 | 2018-12-19 | 9,000 | — | $0 | 36,000 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise deriv | 2018-12-17 | 2018-12-19 | 11,281 | — | $0 | 58,719 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise deriv | 2018-12-17 | 2018-12-19 | 25,002 | — | $0 | 74,998 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | M Exercise deriv | 2018-12-17 | 2018-12-19 | 35,000 | — | $0 | 25,000 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | M Exercise deriv | 2018-12-17 | 2018-12-19 | 14,212 | — | $0 | 45,788 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | M Exercise deriv | 2018-12-17 | 2018-12-19 | 1 | — | $0 | 39,999 | SEC↗ |
| Andriole Michael T. | Chief Financial Officer | M Exercise deriv | 2018-12-17 | 2018-12-19 | 25,000 | — | $0 | 75,000 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise deriv | 2018-12-17 | 2018-12-19 | 2 | — | $0 | 52,498 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise deriv | 2018-12-17 | 2018-12-19 | 20,004 | — | $0 | 59,996 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise deriv | 2018-12-17 | 2018-12-19 | 22,500 | — | $0 | 27,500 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise deriv | 2018-12-17 | 2018-12-19 | 13,089 | — | $0 | 0 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise deriv | 2018-12-17 | 2018-12-19 | 26,177 | — | $0 | 0 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise deriv | 2018-12-17 | 2018-12-19 | 20,000 | — | $0 | 0 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise deriv | 2018-12-17 | 2018-12-19 | 2 | — | $0 | 52,498 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | M Exercise deriv | 2018-12-17 | 2018-12-19 | 5,000 | — | $0 | 15,000 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | M Exercise deriv | 2018-12-17 | 2018-12-19 | 9,531 | — | $0 | 12,969 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | M Exercise deriv | 2018-12-17 | 2018-12-19 | 3,750 | — | $0 | 3,750 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | M Exercise deriv | 2018-12-17 | 2018-12-19 | 9,000 | — | $0 | 0 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | M Exercise deriv | 2018-12-17 | 2018-12-19 | 5,500 | — | $0 | 9,132 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | M Exercise deriv | 2018-12-17 | 2018-12-19 | 16,073 | — | $0 | 0 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise | 2018-12-17 | 2018-12-19 | 21,440 | $9.05 | $194.0K | 365,804 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise | 2018-12-17 | 2018-12-19 | 13,082 | $9.86 | $129.0K | 400,940 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise | 2018-12-17 | 2018-12-19 | 9,000 | $11.11 | $100.0K | 409,940 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise | 2018-12-17 | 2018-12-19 | 20,004 | $3.55 | $71.0K | 387,858 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise | 2018-12-17 | 2018-12-19 | 2,050 | $11.80 | $24.2K | 367,854 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise | 2018-12-17 | 2018-12-19 | 2 | $5.10 | $10 | 409,942 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise | 2018-12-17 | 2018-12-19 | 51,875 | $3.82 | $198.2K | 344,364 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise | 2018-12-17 | 2018-12-19 | 22,759 | $2.54 | $57.8K | 292,489 | SEC↗ |
| Low Philip S | Chief Science Officer | M Exercise | 2018-12-17 | 2018-12-19 | 2 | $3.18 | $6 | 409,944 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise | 2018-12-17 | 2018-12-19 | 3 | $5.10 | $15 | 463,475 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise | 2018-12-17 | 2018-12-19 | 2 | $3.18 | $6 | 463,477 | SEC↗ |
| Sherman Michael A. | President and CEO | G Gift | 2018-12-17 | 2018-12-19 | 84,112 | — | $0 | 379,365 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise | 2018-12-17 | 2018-12-19 | 10,035 | $2.54 | $25.5K | 363,283 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise | 2018-12-17 | 2018-12-19 | 15,706 | $3.82 | $60.0K | 378,989 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise | 2018-12-17 | 2018-12-19 | 5,330 | $2.54 | $13.5K | 353,248 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise | 2018-12-17 | 2018-12-19 | 9,000 | $11.11 | $100.0K | 463,472 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise | 2018-12-17 | 2018-12-19 | 11,281 | $9.86 | $111.2K | 454,472 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise | 2018-12-17 | 2018-12-19 | 25,002 | $3.55 | $88.8K | 443,191 | SEC↗ |
| Sherman Michael A. | President and CEO | M Exercise | 2018-12-17 | 2018-12-19 | 39,200 | $9.05 | $354.8K | 418,189 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | M Exercise | 2018-12-17 | 2018-12-19 | 1 | $2.16 | $2 | 150,253 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | M Exercise | 2018-12-17 | 2018-12-19 | 14,212 | $3.18 | $45.2K | 150,252 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | M Exercise | 2018-12-17 | 2018-12-19 | 35,000 | $5.16 | $180.6K | 136,040 | SEC↗ |
| Andriole Michael T. | Chief Financial Officer | G Gift | 2018-12-17 | 2018-12-19 | 4,500 | — | $0 | 152,582 | SEC↗ |
| Andriole Michael T. | Chief Financial Officer | M Exercise | 2018-12-17 | 2018-12-19 | 25,000 | $2.22 | $55.5K | 157,082 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise | 2018-12-17 | 2018-12-19 | 2 | $5.10 | $10 | 224,254 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise | 2018-12-17 | 2018-12-19 | 20,004 | $3.55 | $71.0K | 224,252 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise | 2018-12-17 | 2018-12-19 | 2 | $3.18 | $6 | 224,256 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise | 2018-12-17 | 2018-12-19 | 22,500 | $9.05 | $203.6K | 204,248 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise | 2018-12-17 | 2018-12-19 | 20,000 | $2.54 | $50.8K | 142,482 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise | 2018-12-17 | 2018-12-19 | 13,089 | $7.49 | $98.0K | 181,748 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise | 2018-12-17 | 2018-12-19 | 26,177 | $3.82 | $100.0K | 168,659 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | G Gift | 2018-12-17 | 2018-12-19 | 1,250 | — | $0 | 101,445 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | G Gift | 2018-12-17 | 2018-12-19 | 2,500 | — | $0 | 102,695 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | M Exercise | 2018-12-17 | 2018-12-19 | 5,000 | $2.16 | $10.8K | 105,195 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | M Exercise | 2018-12-17 | 2018-12-19 | 9,531 | $3.21 | $30.6K | 100,195 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | G Gift | 2018-12-17 | 2018-12-19 | 1,250 | — | $0 | 1,250 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | M Exercise | 2018-12-17 | 2018-12-19 | 9,000 | $5.10 | $45.9K | 86,914 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | M Exercise | 2018-12-17 | 2018-12-19 | 5,500 | $9.86 | $54.2K | 77,914 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | M Exercise | 2018-12-17 | 2018-12-19 | 16,073 | $3.55 | $57.1K | 72,414 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | M Exercise | 2018-12-17 | 2018-12-19 | 3,750 | $3.18 | $11.9K | 90,664 | SEC↗ |
| Low Philip S | Chief Science Officer | G Gift | 2018-12-12 | 2018-12-19 | 52,346 | — | $0 | 269,204 | SEC↗ |
| Low Philip S | Chief Science Officer | G Gift | 2018-12-12 | 2018-12-19 | 52,512 | — | $0 | 132,473 | SEC↗ |
| MIDDLETON FRED A | Director | G Gift | 2018-12-11 | 2018-12-21 | 83,860 | — | $0 | 113,489 | SEC↗ |
| Andriole Michael T. | Chief Financial Officer | S Sale | 2018-10-09 | 2018-10-09 | 635 | $15.85 | $10.1K | 132,082 | SEC↗ |
| Low Philip S | Chief Science Officer | S Sale | 2018-10-05 | 2018-10-09 | 5,928 | $15.56 | $92.2K | 319,817 | SEC↗ |
| Parker Katherine | VP of Human Resources | S Sale | 2018-10-05 | 2018-10-09 | 6,771 | $15.55 | $105.3K | 70,349 | SEC↗ |
| Chelius Erik C. | Vice President CMC | S Sale | 2018-10-05 | 2018-10-09 | 4,514 | $15.56 | $70.2K | 49,895 | SEC↗ |
| Andriole Michael T. | Chief Financial Officer | S Sale | 2018-10-05 | 2018-10-09 | 17,283 | $15.55 | $268.8K | 132,717 | SEC↗ |
| Sherman Michael A. | President and CEO | S Sale | 2018-10-05 | 2018-10-09 | 28,146 | $15.55 | $437.7K | 347,918 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | S Sale | 2018-10-05 | 2018-10-09 | 7,022 | $15.56 | $109.3K | 56,341 | SEC↗ |
| Leamon Christopher P | Vice President of Research | S Sale | 2018-10-05 | 2018-10-09 | 9,028 | $15.56 | $140.5K | 121,353 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | S Sale | 2018-10-05 | 2018-10-09 | 9,111 | $15.56 | $141.8K | 101,040 | SEC↗ |
| Leamon Christopher P | Vice President of Research | S Sale | 2018-10-05 | 2018-10-16 | 9,028 | $15.56 | $140.5K | 122,219 | SEC↗ |
| Parker Katherine | VP of Human Resources | S Sale | 2018-10-05 | 2018-10-16 | 6,771 | $15.55 | $105.3K | 70,869 | SEC↗ |
| Low Philip S | Chief Science Officer | S Sale | 2018-10-05 | 2018-10-16 | 5,928 | $15.56 | $92.2K | 321,550 | SEC↗ |
| Low Philip S | Chief Science Officer | G Gift | 2018-09-07 | 2018-10-09 | 294 | — | $0 | 325,745 | SEC↗ |
| Low Philip S | Chief Science Officer | G Gift | 2018-09-07 | 2018-10-16 | 294 | — | $0 | 327,478 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise deriv | 2018-08-29 | 2018-08-29 | 4,696 | — | $0 | 20,000 | SEC↗ |
| Leamon Christopher P | Vice President of Research | S Sale | 2018-08-29 | 2018-08-29 | 4,696 | $20.00 | $93.9K | 130,381 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise | 2018-08-29 | 2018-08-29 | 4,696 | $2.54 | $11.9K | 135,077 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise deriv | 2018-08-28 | 2018-08-29 | 12,670 | — | $0 | 24,696 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | S Sale | 2018-08-28 | 2018-08-29 | 7,892 | $20.00 | $157.8K | 63,363 | SEC↗ |
| Leamon Christopher P | Vice President of Research | M Exercise | 2018-08-28 | 2018-08-29 | 12,670 | $2.54 | $32.2K | 143,051 | SEC↗ |
| Leamon Christopher P | Vice President of Research | S Sale | 2018-08-28 | 2018-08-29 | 12,670 | $20.00 | $253.4K | 130,381 | SEC↗ |
| Taylor Beth | VP Finance & Chief Acctg Off | S Sale | 2018-08-20 | 2018-08-22 | 285 | $18.20 | $5.2K | 71,255 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | S Sale | 2018-08-01 | 2018-08-02 | 1,414 | $15.98 | $22.6K | 110,151 | SEC↗ |
| Leamon Christopher P | Vice President of Research | S Sale | 2018-06-12 | 2018-06-13 | 13,089 | $15.06 | $197.1K | 130,381 | SEC↗ |
| Svoronos Dawn | Director | A Award deriv | 2018-05-03 | 2018-05-04 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Machado Patrick | Director | A Award deriv | 2018-05-03 | 2018-05-04 | 19,500 | — | $0 | 19,500 | SEC↗ |
| Russell Lesley | Director | A Award deriv | 2018-05-03 | 2018-05-04 | 19,500 | — | $0 | 19,500 | SEC↗ |
| APLIN JOHN C | Director | A Award deriv | 2018-05-03 | 2018-05-04 | 19,500 | — | $0 | 19,500 | SEC↗ |
| MIDDLETON FRED A | Director | A Award deriv | 2018-05-03 | 2018-05-04 | 19,500 | — | $0 | 19,500 | SEC↗ |
| GODDARD COLIN | Director | A Award deriv | 2018-05-03 | 2018-05-04 | 19,500 | — | $0 | 19,500 | SEC↗ |
| KOZIN MARC D | Director | A Award deriv | 2018-05-03 | 2018-05-04 | 19,500 | — | $0 | 19,500 | SEC↗ |
| Svoronos Dawn | Director | A Award | 2018-05-03 | 2018-05-04 | 7,050 | — | $0 | 7,050 | SEC↗ |
| Machado Patrick | Director | A Award | 2018-05-03 | 2018-05-04 | 3,300 | — | $0 | 7,050 | SEC↗ |
| Russell Lesley | Director | A Award | 2018-05-03 | 2018-05-04 | 3,300 | — | $0 | 11,100 | SEC↗ |
| APLIN JOHN C | Director | A Award | 2018-05-03 | 2018-05-04 | 3,300 | — | $0 | 32,163 | SEC↗ |
| MIDDLETON FRED A | Director | A Award | 2018-05-03 | 2018-05-04 | 3,300 | — | $0 | 197,349 | SEC↗ |
| GODDARD COLIN | Director | A Award | 2018-05-03 | 2018-05-04 | 3,300 | — | $0 | 11,100 | SEC↗ |
| KOZIN MARC D | Director | A Award | 2018-05-03 | 2018-05-04 | 3,300 | — | $0 | 11,100 | SEC↗ |
| Leamon Christopher P | Vice President of Research | S Sale | 2018-03-09 | 2018-03-12 | 5,036 | $9.07 | $45.7K | 143,470 | SEC↗ |
| MIDDLETON FRED A | Director | A Award | 2018-02-28 | 2018-03-01 | 380,952 | $4.20 | $1.60M | 1,212,413 | SEC↗ |
| MIDDLETON FRED A | Director | A Award | 2018-02-28 | 2018-03-01 | 119,048 | $4.20 | $500.0K | 904,465 | SEC↗ |
| Machado Patrick | Director | A Award deriv | 2018-02-27 | 2018-03-01 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Machado Patrick | Director | A Award | 2018-02-27 | 2018-03-01 | 3,750 | — | $0 | 3,750 | SEC↗ |
| Andriole Michael T. | Chief Financial Officer | A Award deriv | 2018-02-08 | 2018-02-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Armour Alison A. | Chief Medical Officer | A Award deriv | 2018-02-08 | 2018-02-08 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Chelius Erik C. | Vice President CMC | A Award deriv | 2018-02-08 | 2018-02-08 | 47,500 | — | $0 | 47,500 | SEC↗ |
| Leamon Christopher P | Vice President of Research | A Award deriv | 2018-02-08 | 2018-02-08 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Low Philip S | Chief Science Officer | A Award deriv | 2018-02-08 | 2018-02-08 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Parker Katherine | VP of Human Resources | A Award deriv | 2018-02-08 | 2018-02-08 | 25,000 | — | $0 | 25,000 | SEC↗ |